Seeking Cures For

sensory-neuronsAll 16 of our Taubman Scholars are practicing physicians whose patients are an ever-present reminder of the urgent need for new cures and therapies.  Their areas of expertise range from stroke and heart attack to ALS to the vision loss that is a common complication of diabetes. 

A number of our scientists are seeking new treatments for a range of cancers – including a common childhood cancer – while others are working to understand conditions like obesity and skin diseases.

In just three short years, Taubman Scholars have published 94 articles in leading scientific journals, and Taubman Institute support has led to 10 human clinical trials of new treatments for disease.

To read more about how each Scholar’s approach targets specific diseases, click on the links to their research outline.

Amyotrophic lateral sclerosis (ALS)

Eva L. Feldman, M.D., Ph.D., F.A.A.N.

Cancer

Ronald J. Buckanovich, M.D., Ph.D.
Valerie P. Castle, M.D.
Arul M. Chinnaiyan, M.D., Ph.D.
Theodore s. Lawrence, M.D., Ph.D.
Erika A. Newman, M.D.
Kenneth J. Pienta, M.D.
Max S. Wicha, M.D.

Diabetes and complications of diabetes

Frank C. Brosius III, M.D.
Thomas Gardner, M.D., M.S.

Heart attack and stroke

David Ginsburg, M.D.
David J. Pinsky, M.D.

Motor neuron disease

Nicholas M. Boulis, M.D.

Muscle diseases

James Dowling, M.D., Ph.D.

Obesity

Charles F. Burant, M.D., Ph.D.

Skin diseases

Johann E. Gudjonsson, M.D., Ph.D.

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists